Gossamer Bio, Inc. (LSX:A2PCBS) Financings

Gossamer Bio, Inc.

Financings

RaiseDate
Private placement of pre-funded warrants and FDA approval warrants
Announced: up to US$250M · US$0.1399 a share · Warrants at US$0.187 · Leerink Partners +1
Dealers: Leerink Partners (co-lead), Cantor (co-lead)
Buyers: EcoR1 Capital; 683 Capital Partners, LP; RA Capital Management; Coastlands Capital; Samsara BioCapital; Rock Springs Capital
Use of proceeds: Advance clinical development and potential commercialization of seralutinib in PAH and PH-ILD, general corporate purposes and working capital
Aug 21, 2026

Read by 6ix AI from the company's releases